Complete Story
05/14/2018
A Message From Your E-bulletin Sponsor
Merck-KEYTRUDA®
April 2018 New England Journal of Medicine publication that discusses KEYTRUDA® (pembrolizumab) Injection 100 mg.
CLICK HERE to access the April 2018 New England Journal of Medicine publication which discusses KEYTRUDA® (pembrolizumab) Injection 100 mg.
Report Broken Links
Have you encountered a problem with a URL (link) on this page not working or displaying an error message? Help us fix it!